Hanmi Pharm Q3 revenue ₩377.4B; operating and net profit down year on year
Predicted impact: Low
Q3 results already reported; profit decline was flagged in earlier items.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.